Atlas Trials

Biomarker for Infection Risk in CLL and MM

Clinical trial NCT05844033 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05844033
Sponsor
Massachusetts General Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Multiple MyelomaChronic Lymphocytic Leukemia
Start date
2023-08-01
Primary completion
2026-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.